Press Release March 18, 2022Amneal Awarded Sub-License to Manufacture and Commercialize Generic Version of Co-Packaged Nirmatrelvir and Ritonavir in 95 Low- and Middle-Income Countries 0 0 Share
Company Ticker News March 2, 2022Amneal Reports Fourth Quarter and Full Year 2021 Financial Results 0 0 Share
Company Ticker News February 4, 2022Amneal to Report Fourth Quarter and Full Year 2021 Results on March 2, 2022 0 0 Share
Company Ticker News February 4, 2022Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year? 0 0 Share
Company Ticker News January 28, 2022Is Amneal Pharmaceuticals (AMRX) a Suitable Pick for Value Investors? 0 0 Share
Company Ticker News January 5, 2022Amneal's $83M Saol Acquisition Deal Expands Its Neurology Presence Into Spasticity 0 0 Share
Press Release December 21, 2021Amneal to Virtually Participate at the 40th Annual J.P. Morgan Healthcare Conference 0 0 Share
